Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for X-Linked Agammaglobulinemia Clinical Trials
X-Linked Agammaglobulinemia clinical trials are recruiting across 1 cities. Here are the cities with the most active studies:
About X-Linked Agammaglobulinemia
X-linked agammaglobulinemia is a rare genetic immune disorder in which the body is unable to produce B cells or immunoglobulins, leaving patients highly susceptible to infections. It primarily affects males. Treatment includes lifelong immunoglobulin replacement therapy.
Clinical trials are advancing new treatments for x-linked agammaglobulinemia. Currently, 1 studies are recruiting a combined 500 participants across the United States. Research is being conducted by 1 organizations including National Institute of Allergy and Infectious Diseases (NIAID).
2026 X-Linked Agammaglobulinemia Research Landscape
As of July 2026, the x-linked agammaglobulinemia clinical trial landscape includes 1 actively recruiting studies across 1 cities in the United States. These studies are collectively seeking 500 participants, with an average enrollment target of 500 per study.
Research is being led by 1 organization, including National Institute of Allergy and Infectious Diseases (NIAID).
Geographically, x-linked agammaglobulinemia trials are most concentrated in Bethesda, Maryland (1 trial).
Featured X-Linked Agammaglobulinemia Studies
Highlighted recruiting studies for x-linked agammaglobulinemia, selected by enrollment size and research scope.
Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)
This study aims to understand the causes and progression of Common Variable Immunodeficiency (CVID) and related inborn errors of immunity (IEI). These are conditions where the immune system does not function properly, leading to frequent infections and other complications such as gastrointestinal inflammation, lung and liver disease, autoimmune conditions, and an increased risk of certain cancers....
Frequently Asked Questions About X-Linked Agammaglobulinemia Clinical Trials
Are there x-linked agammaglobulinemia clinical trials near me?
Yes, there are 1 x-linked agammaglobulinemia clinical trials currently recruiting across 1+ cities in the United States, including Bethesda, Maryland. Browse the studies above to find one at a location convenient for you.
How do I join a x-linked agammaglobulinemia clinical trial?
To join a x-linked agammaglobulinemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are x-linked agammaglobulinemia clinical trials free?
Yes, participation in x-linked agammaglobulinemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of x-linked agammaglobulinemia treatments are being studied?
Current x-linked agammaglobulinemia clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in x-linked agammaglobulinemia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 14, 2026 · Data from ClinicalTrials.gov